Morelli D - Search Results

1

Purification of interleukin-2 antibodies from healthy individuals.

Monti E, Pozzi A, Tiberio L, Morelli D, Caruso A, Villa ML, Balsari A. Monti E, et al. Among authors: morelli d. Immunol Lett. 1993 Jun;36(3):261-6. doi: 10.1016/0165-2478(93)90098-m. Immunol Lett. 1993. PMID: 8370597

2

The detection and biological activity of human antibodies to IL-2 in normal donors.

Tiberio L, Caruso A, Pozzi A, Rivoltini L, Morelli D, Monti E, Balsari A. Tiberio L, et al. Among authors: morelli d. Scand J Immunol. 1993 Nov;38(5):472-6. doi: 10.1111/j.1365-3083.1993.tb02590.x. Scand J Immunol. 1993. PMID: 8235450

3

Segregation of type 1 cytokine production in human peripheral blood lymphocytes: phenotypic differences between IFN-gamma and IL-2-producing cells in the CD8+ T cell subset.

Caruso A, Licenziati S, Morelli D, Fiorentini S, Ricotta D, Malacarne F, Sfondrini L, Balsari A. Caruso A, et al. Among authors: morelli d. Eur J Immunol. 1998 Nov;28(11):3630-8. doi: 10.1002/(SICI)1521-4141(199811)28:11<3630::AID-IMMU3630>3.0.CO;2-6. Eur J Immunol. 1998. PMID: 9842905 Free article.

4

Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin.

Morelli D, Sardini A, Villa E, Villa ML, Ménard S, Colnaghi MI, Balsari A. Morelli D, et al. Cancer Immunol Immunother. 1994 Mar;38(3):171-7. doi: 10.1007/BF01525638. Cancer Immunol Immunother. 1994. PMID: 8124685 Free PMC article.

5

Relevance of antibody valency in EGF receptor modulation.

Morelli D, Villa E, Tagliabue E, Perletti L, Villa ML, Ménard S, Balsari A, Colnaghi MI. Morelli D, et al. Scand J Immunol. 1994 May;39(5):453-8. doi: 10.1111/j.1365-3083.1994.tb03400.x. Scand J Immunol. 1994. PMID: 8191221

6

A new monoclonal antibody recognizing anthracyclinic molecule.

Balsari A, Morelli D, Menard S, Tagliabue E, Colnaghi MI, Ghione M. Balsari A, et al. Among authors: morelli d. Anticancer Res. 1990 Jan-Feb;10(1):129-32. Anticancer Res. 1990. PMID: 1692196

7

The differential response to interferon gamma by normal and transformed endothelial cells.

Maier JA, Morelli D, Balsari A. Maier JA, et al. Among authors: morelli d. Biochem Biophys Res Commun. 1995 Sep 14;214(2):582-8. doi: 10.1006/bbrc.1995.2325. Biochem Biophys Res Commun. 1995. PMID: 7677768

8

Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line.

Maier JA, Morelli D, Ménard S, Colnaghi MI, Balsari A. Maier JA, et al. Among authors: morelli d. Am J Pathol. 1996 Sep;149(3):945-52. Am J Pathol. 1996. PMID: 8780398 Free PMC article.

9

A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.

Morelli D, Pozzi B, Maier JA, Ménard S, Colnaghi MI, Balsari A. Morelli D, et al. Nucleic Acids Res. 1995 Nov 25;23(22):4603-7. doi: 10.1093/nar/23.22.4603. Nucleic Acids Res. 1995. PMID: 8524649 Free PMC article.

10

Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies.

Balsari AL, Morelli D, Ménard S, Veronesi U, Colnaghi MI. Balsari AL, et al. Among authors: morelli d. FASEB J. 1994 Feb;8(2):226-30. doi: 10.1096/fasebj.8.2.8119493. FASEB J. 1994. PMID: 8119493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters